HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of glycoprotein B and immediate early-1 genotypes with human leukocyte antigen alleles in renal transplant recipients with cytomegalovirus infection.

AbstractBACKGROUND:
Numerous risk factors for cytomegalovirus (CMV) infection or disease, or both, such as serostatus of donor and recipient, immunosuppressive regimen, or intensity of viral load, have been identified in renal transplant recipients. Additional parameters may be involved, notably, genetic variability of both host and virus, which could modulate the efficacy of the immune response.
METHODS:
Active CMV infection was analyzed retrospectively in 634 renal transplant recipients, according to human leukocyte antigen (HLA)-A, HLA-B, and HLA-DR alleles; CMV serostatus; presentation of the disease; and variations in the coding sequences of glycoprotein (g) B and IE1 proteins.
RESULTS:
Active infection occurred in 141 of 634 patients: seropositivity of the donor and the recipient were identified as risk factors. Patients carrying the HLA-A11, HLA-A32, or HLA-DR11 allele developed active infection more frequently, whereas none of the patients with the HLA-B16 or HLA-B55 allele was actively infected. Significant independent associations between some genotypes and particular HLA alleles were observed: gB1 was more frequent in the HLA-A24 or HLA-B7 context and underrepresented in patients with HLA-DR11; gB2 was more frequent in HLA-A32 or HLA-DR11 carriers; and an increased frequency of gB3 was observed in the HLA-A29 context. Considering the IE1-2 genotype, increased frequency was noted for HLA-A3 carriers, whereas this type was underrepresented for patients with the HLA-DR11 allele.
CONCLUSION:
Data strongly suggest that differential presentation of polymorphic gB or IE peptides by HLA molecules or differential recognition by host CD8+ and CD4+ T lymphocytes, or both, should modulate immunologic response and then CMV pathogenesis in renal transplant patients.
AuthorsChristelle Retière, Béatrice Lesimple, Didier Lepelletier, Jean-Denis Bignon, Marie-Martine Hallet, Berthe-Marie Imbert-Marcille
JournalTransplantation (Transplantation) Vol. 75 Issue 1 Pg. 161-5 (Jan 15 2003) ISSN: 0041-1337 [Print] United States
PMID12544891 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA Antigens
  • HLA-B Antigens
  • HLA-DR Antigens
  • IE-1 protein, murine cytomegalovirus
  • Immediate-Early Proteins
  • Trans-Activators
  • Viral Envelope Proteins
  • glycoprotein B, Simplexvirus
Topics
  • Alleles
  • Cytomegalovirus Infections (genetics, immunology)
  • Genotype
  • HLA Antigens (genetics)
  • HLA-B Antigens (genetics)
  • HLA-DR Antigens (genetics)
  • Humans
  • Immediate-Early Proteins (genetics)
  • Kidney Transplantation (adverse effects)
  • Retrospective Studies
  • Trans-Activators (genetics)
  • Viral Envelope Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: